One week, a headline tells you something is killing you. If you follow health research closely, this pattern becomes familiar quickly. A few years later, a different headline tells you it’s fine, possibly even beneficial. Then another study reverses that. If you’ve been paying attention to health news for any length of time, the obvious conclusion is that nobody knows anything.
That’s not quite right. But the pattern in health research is real, and it has a few straightforward explanations.
How a study becomes a headline
Most health research doesn’t conclude with certainty. It concludes with a finding that is statistically significant. That means something specific and limited: that the result is unlikely to have occurred by chance alone. It does not mean the effect is large. It does not mean the study is definitive. It means the researchers found something worth reporting.
Between that finding and a newspaper headline, a lot of information gets lost. Effect sizes disappear. Confidence intervals vanish. “Associated with” becomes “causes.” “In a sample of 300 adults over six weeks” becomes “scientists say.”
This is not always bad faith. Nuance is hard to headline. But the result is a public understanding of health science that swings between extremes in ways that the science itself rarely does.
Health research and relative risk versus absolute risk
One of the most useful distinctions in health reporting, and one of the most consistently ignored, is the difference between relative and absolute risk.
If something doubles your risk of a rare condition, that sounds alarming. But if your baseline risk is one in a thousand, doubling it takes you to two in a thousand. The relative increase is one hundred percent. The absolute increase is one in a thousand.
Both numbers are accurate. They tell you very different things about how worried to be. Journalists and press releases tend to prefer the one that sounds more dramatic.
The problem of funding
The other significant variable in health research is who paid for it.
Industry-funded studies don’t automatically produce false results. But they do tend to produce results that are more favourable to the funder’s interests. Not through fraud, necessarily, but through the quieter mechanisms of question selection, study design, and publication choices. Studies that produce inconvenient findings are less likely to be submitted for publication. Studies designed in a way that slightly favours a particular outcome are more likely to get funded in the first place.
This is documented across multiple industries. It’s not a conspiracy theory. It’s a structural problem with how science gets paid for.
What this means for anyone reading health news
The honest answer is that you can’t evaluate every study you encounter. Most people don’t have the time or the training, and even experts disagree about individual pieces of research.
What you can do is develop a few habits of scepticism. Who funded it? What was the sample size and duration? Is this one study or a pattern across many? Is the effect size actually meaningful, or just statistically significant? Is the headline claiming causation when the study only found correlation?
None of this makes you a scientist. It makes you a slightly more careful reader. That’s all that’s being asked.
The knowledge is available. The picture it points to, across decades of careful accumulation, is often clearer than the week-by-week noise suggests. The trick is learning to look at the picture rather than the individual headlines.
The Quiet Con by Ian Wilkinson expands this argument into a full account of how drinking was made to feel normal, harmless, and beyond serious question. Paperback £9.99. Kindle £2.99. Free on Kindle Unlimited. Read more about the book, see edition details, and buy your copy here. This is part of a broader pattern of how the alcohol industry funds its own research to shape what enters the public conversation.